Haemonetics Corp (HAE)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$60.00

Buy

$73.37

arrow-up$0.93 (+1.34%)

Prices updated at 16 May 2025, 23:42 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.

Income statement

20232024
1,169m1,309m
615m692m
156m173m
13.3213.24
115m118m
249m262m
Sales, General and administrative377m432m
Interest expenses15m13m
Provision for income taxes26m34m
Operating expenses459m518m
Income before taxes141m152m
Net income available to common shareholders115m118m
2.52.56
Net interest income-15m-13m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)2.462.54
Free cash flow per share3.88260.3958
Book value/share17.596917.4948
Debt equity ratio0.9218880.830831

Balance sheet

20232024
Current assets770m769m
Current liabilities252m300m
Total capital1,572m1,758m
Total debt766m808m
Total equity818m960m
Total non current liabilities--
Loans754m798m
Total assets1,935m2,196m
Total liabilities--
Cash and cash equivalents284m179m
Common stock50m51m

Cash flow

20232024
Cash at beginning of period259m284m
Cash dividends paid--
163m115m
Investments (gains) losses-144m-322m
284m179m
Net income--
273m182m
-110m-66m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.